These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37629369)

  • 1. Quality of Life 6 Months after COVID-19 Hospitalisation: A Single-Centre Polish Registry.
    Koźlik M; Kaźmierski M; Kaźmierski W; Lis P; Lis A; Łowicka W; Chamera M; Romanowska B; Kufel J; Cebula M; Jędrzejek M
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir for the treatment of COVID-19.
    Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine for the treatment of COVID-19.
    Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
    Liew J; Gianfrancesco M; Harrison C; Izadi Z; Rush S; Lawson-Tovey S; Jacobsohn L; Ja C; Hyrich KL; Gossec L; Strangfeld A; Carmona L; Schäfer M; Frãzao-Mateus E; Bulina I; Stafford F; Tufan A; Graver C; Yardımcı GK; Zepa J; Al Emadi S; Cook C; Abutiban F; Dey D; Katigbak G; Kaufman L; Kowalski E; Martínez-Martínez MU; Patel NJ; Reyes-Cordero G; Salido E; Smith E; Snow D; Sparks J; Wise L; Bhana S; Gore-Massy M; Grainger R; Hausmann J; Sirotich E; Sufka P; Wallace Z; Machado PM; Robinson PC; Yazdany J
    RMD Open; 2022 Apr; 8(1):. PubMed ID: 35387864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
    Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
    Elife; 2023 Jan; 12():. PubMed ID: 36692910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of vaccination for preventing hospitalisation with COVID-19 in regional Queensland: a data linkage study.
    Smoll NR; Al Imam MH; Shulz C; Booy R; Khandaker G
    Med J Aust; 2023 Aug; 219(4):162-165. PubMed ID: 37400415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of COVID-19 disease and fear of the SARS-CoV-2 virus among Polish students.
    Turska E; Stępień-Lampa N; Grzywna P
    PeerJ; 2022; 10():e14356. PubMed ID: 36530393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.
    Martínez-Baz I; Trobajo-Sanmartín C; Miqueleiz A; Casado I; Navascués A; Burgui C; Ezpeleta C; Castilla J; Guevara M; ;
    Euro Surveill; 2023 Feb; 28(5):. PubMed ID: 36729113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study.
    Piernas C; Patone M; Astbury NM; Gao M; Sheikh A; Khunti K; Shankar-Hari M; Dixon S; Coupland C; Aveyard P; Hippisley-Cox J; Jebb SA
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):571-580. PubMed ID: 35780805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of isolation on the biopsychosocial functioning of older people with COVID-19.
    Wróblewska IM; Chmielewski JP; Wojciechowska M; Chmielowiec B; Nowak-Starz G; Szarpak L; Florek-Łuszczki M
    Ann Agric Environ Med; 2022 Dec; 29(4):560-567. PubMed ID: 36583324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland.
    Anderegg N; Althaus CL; Colin S; Hauser A; Laube A; Mäusezahl M; Wagner M; Zaffora B; Riou J
    Swiss Med Wkly; 2022 Apr; 152():w30163. PubMed ID: 35752951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
    Pizarro AB; Persad E; Durao S; Nussbaumer-Streit B; Engela-Volker JS; McElvenny D; Rhodes S; Stocking K; Fletcher T; Martin C; Noertjojo K; Sampson O; Verbeek JH; Jørgensen KJ; Bruschettini M
    Cochrane Database Syst Rev; 2022 May; 5(5):CD015112. PubMed ID: 35514111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
    Pinato DJ; Aguilar-Company J; Ferrante D; Hanbury G; Bower M; Salazar R; Mirallas O; Sureda A; Plaja A; Cucurull M; Mesia R; Townsend S; Jackson A; Dalla Pria A; Newsom-Davis T; Handford J; Sita-Lumsden A; Apthorp E; Vincenzi B; Bertuzzi A; Brunet J; Lambertini M; Maluquer C; Pedrazzoli P; Biello F; Sinclair A; Bawany S; Khalique S; Rossi S; Rogers L; Murphy C; Belessiotis K; Carmona-García MC; Sharkey R; García-Illescas D; Rizzo G; Perachino M; Saoudi-Gonzalez N; Doonga K; Fox L; Roldán E; Gaidano G; Ruiz-Camps I; Bruna R; Patriarca A; Martinez-Vila C; Cantini L; Zambelli A; Giusti R; Mazzoni F; Caliman E; Santoro A; Grosso F; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Prat A; Tucci M; Libertini M; Grisanti S; Mukherjee U; Diamantis N; Fusco V; Generali D; Provenzano S; Gennari A; Tabernero J; Cortellini A;
    Lancet Oncol; 2022 Jul; 23(7):865-875. PubMed ID: 35660139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study.
    Risk M; Hayek SS; Schiopu E; Yuan L; Shen C; Shi X; Freed G; Zhao L
    Lancet Rheumatol; 2022 Nov; 4(11):e775-e784. PubMed ID: 35991760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in Pediatric Intensive Care Units in Poland, PAPITCO-19 Study (Polish Analysis of PICU Trends during COVID-19).
    Damps M; Byrska-Maciejasz E; Kowalska M; Rosada-Kurasińska J; Rybojad B; Sordyl J; Zielińska M; Bartkowska-Śniatkowska A; On Behalf Of The Papitco-Group
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.